Predicting Relapse with Circulating Tumor DNA Analysis in Lung Cancer.
MetadataShow full item record
<b/> Advances in circulating tumor DNA (ctDNA) analysis are revealing new treatment strategies for patients with cancer. Detection of residual disease with ctDNA analysis predicts relapse with high accuracy after treatment for early-stage lung cancer. Cancer Discov; 7(12); 1368-70. ©2017 AACRSee related article by Chaudhuri et al., p. 1394.
Version of record
Cancer Discov, 7 (12), pp. 1368 - 1370